pirfenidone vivanta 801 mg tabletti, kalvopäällysteinen
vivanta generics s.r.o. - pirfenidone - tabletti, kalvopäällysteinen - 801 mg - pirfenidoni
pirfenidone vivanta 267 mg tabletti, kalvopäällysteinen
vivanta generics s.r.o. - pirfenidone - tabletti, kalvopäällysteinen - 267 mg - pirfenidoni
sunitinib vivanta 50 mg kapseli, kova
vivanta generics s.r.o. - sunitinib malate - kapseli, kova - 50 mg - sunitinibi
sunitinib vivanta 37.5 mg kapseli, kova
vivanta generics s.r.o. - sunitinib malate - kapseli, kova - 37.5 mg - sunitinibi
sunitinib vivanta 25 mg kapseli, kova
vivanta generics s.r.o. - sunitinib malate - kapseli, kova - 25 mg - sunitinibi
sunitinib vivanta 12.5 mg kapseli, kova
vivanta generics s.r.o. - sunitinib malate - kapseli, kova - 12.5 mg - sunitinibi
teriflunomide vivanta 14 mg tabletti, kalvopäällysteinen
vivanta generics s.r.o. - teriflunomide - tabletti, kalvopäällysteinen - 14 mg - teriflunomidi
plerixafor vivanta 20 mg/ml injektioneste, liuos
vivanta generics s.r.o. - plerixafor - injektioneste, liuos - 20 mg/ml - pleriksafori
qaialdo
nova laboratories ireland limited - spironolaktoni - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 ja 5.
bortezomib msn 3.5 mg injektiokuiva-aine, liuosta varten
vivanta generics s.r.o. - bortezomib - injektiokuiva-aine, liuosta varten - 3.5 mg - bortetsomibi